Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green
UM, Carrillo R, Cha YM, Clancy J, Deharo JC, Ellenbogen KA, Exner D,
Hussein AA, Kennergren C, Krahn A, Lee R, Love CJ, Madden RA, Mazzetti
HA, Moore JC, Parsonnet J, Patton KK, Rozner MA, Selzman KA, Shoda M,
Srivathsan K, Strathmore NF, Swerdlow CD, Tompkins C, Wazni O. 2017
HRS expert consensus statement on cardiovascular implantable
electronic device lead management and extraction. Heart Rhythm.
2017;14:e503-e551.
Baddour LM, Cha YM, Wilson WR. Clinical practice: infections of
cardiovascular implantable electronic devices. N Engl J Med
2012;367:842-849.
Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis,
prevention and management of implantable cardiac electronic device
infection: report of a joint Working Party project on behalf of the
British Society for Antimicrobial Chemotherapy (BSAC, host
organization), British Heart Rhythm Society (BHRS), British
Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and
British Society for Echocardiography (BSE). J Antimicrob Chemother
2015;70:325-359.
Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ.
Mortality and cost associated with cardiovascular implantable
electronic device infections. Arch Intern Med 2011;171:1821-1828.
Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S,
Uslan DZ. Rates of and factors associated with infection in 200909
Medicare implantable cardioverter-defibrillator implants: results from
the National Cardiovascular Data Registry. Circulation
2014;130:1037-1043.
Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major
hemorrhage and tolerability of warfarin in the first year of therapy
among elderly patients with atrial fibrillation. Circulation
2007;115:2689-2696.
Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, St Sauver
JL, Hayes DL. Temporal trends in permanent pacemaker implantation: a
population- based study. Am Heart J 2008;155:896-903.
Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and
gender trends in implantable cardioverter defibrillator utilization: a
population based study. J Interv Card Electrophysiol 2008;22:65-70.
Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac
implantable electronic device infection: a systematic review and
meta-analysis. Europace. 2015;17:767-777.
Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey
JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S;
PEOPLE Study Group. Risk factors related to infections of implanted
pacemakers and cardioverter-defibrillators: results of a large
prospective study. Circulation. 2007;116:1349-1355.
Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF,
Friedman PA, Estes NA 3rd, Ip J, Niazi I, Plunkitt K, Banker R,
Porterfield J, Ip JE, Dukkipati SR; LEAD- LESS II Study Investigators:
Percutaneous implantation of an entirely intracardiac leadless
pacemaker. N Engl J Med 2015;373: 1125-1135.
El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL,
Piccini JP, Iacopino S, Lloyd M, Viñolas Prat X, Jacobsen MD, Ritter
P, Johansen JB, Tondo C, Liu F, Fagan DH, Eakley AK, Roberts PR.
Updated performance of the Micra transcatheter pacemaker in the
real-world setting: A comparison to the investigational study and a
transvenous historical control. Heart Rhythm. 2018;15:1800-1807.
Beurskens NEG, Tjong FVY, Dasselaar KJ, Kuijt WJ, Wilde AAM, Knops RE.
Leadless pacemaker implantation after explantation of infected
conventional pacemaker systems: A viable solution? Heart Rhythm.
2019;16:66-71.
Kypta A, Blessberger H, Kammler J, Lambert T, Lichtenauer M,
Brandstaetter W, Gabriel M, Steinwender C. Leadless Cardiac Pacemaker
Implantation After Lead Extraction in Patients With Severe Device
Infection. J Cardiovasc Electrophysiol. 2016;27:1067-1071.
El-Chami MF, Johansen JB, Zaidi A, Faerestrand S, Reynolds D,
Garcia-Seara J, Mansourati J, Pasquie JL, McElderry HT, Roberts PR,
Soejima K, Stromberg K, Piccini JP. Leadless pacemaker implant in
patients with pre-existing infections: Results from the Micra post
approval registry. J Cardiovasc Electrophysiol. 2019;30:569-574.
Zucchelli G, Barletta V, Della Tommasina V, Viani S, Parollo M,
Mazzocchetti L, Cellamaro T, Paperini L, Di Cori A, De Lucia R,
Segreti L, Soldati E, Bongiorni MG. Micra pacemaker implant after
cardiac implantable electronic device extraction: feasibility and
long-term outcomes. Europace. 2019;21:1229-1236.
Chang D, Gabriels JK, Soo Kim B, Ismail H, Willner J, Beldner SJ, John
RM, Epstein LM. Concomitant leadless pacemaker implantation and lead
extraction during an active infection. J Cardiovasc Electrophysiol.
2020;31:860-867.
Higuchi S, Shoda M, Saito S, Kanai M, Kataoka S, Yazaki K, Yagishita
D, Ejima K, Hagiwara N. Safety and efficacy of transvenous lead
extractions for noninfectious superfluous leads in a Japanese
population: A single-center experience. Pacing Clin Electrophysiol.
2019;42:1517-1523.
Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, Karim
SS, Bashir J, Greenspon AJ, DiMarco JP, Cooper JM, Onufer JR,
Ellenbogen KA, Kutalek SP, Dentry-Mabry S, Ervin CM, Wilkoff BL. Lead
extraction in the contemporary setting: the LExICon study: an
observational retrospective study of consecutive laser lead
extractions. J Am Coll Cardiol. 2010;55:579-586.
Rodriguez Y, Garisto JD, Carrillo RG. Laser lead extraction in the
octogenarian patient. Circ Arrhythm Electrophysiol. 2011;4:719-723.
Pelargonio G, Narducci ML, Russo E, Casella M, Santangeli P, Canby R,
Al-Ahmad A, Price LD, Di Biase L, Kwark CJ, Harwood M, Perna F,
Bencardino G, Ierardi C, Trecarichi EM, Santelli E, Tumbarello M,
Mohanty P, Bailey S, Burkhardt JD, Bellocci F, Natale A, Dello Russo
A. Safety and effectiveness of transvenous lead extraction in
octogenarians. J Cardiovasc Electrophysiol. 2012;23:1103-1108.
Kutarski A, Polewczyk A, Boczar K, Ząbek A, Polewczyk M. Safety and
effectiveness of transvenous lead extraction in elderly patients.
Cardiol J. 2014;21:47-52.
Fanari Z, Hammami S, Hammami MB, Hammami S, Shuraih M. The effects of
right ventricular apical pacing with transvenous pacemaker and
implantable cardioverter
defibrillator on mitral and tricuspid regurgitation. J Electrocardiol.
2015;48:791-797.
Kypta A, Blessberger H, Kammler J, Lichtenauer M, Lambert T, Silye R,
Steinwender C: First autopsy description of changes 1 year after
implantation of a leadless cardiac pacemaker: Unexpected ingrowth and
severe chronic inflammation. Can J Cardiol 2015. pii: S0828-
282X:01699-2.
Higuchi S, Shoda M, Satomi N, Iwanami Y, Yagishita D, Ejima K,
Hagiwara N. Unique abdominal twiddler syndrome. J Arrhythm.
2019;35:142-144.